Cameron John Reynolds, President and CEO at VOLITIONRX LTD (VNRX), bought 3,500 shares at $1.61 ($6K) on 2022-08-30, disclosed to the SEC on 2022-08-30.
Open-market purchase of $6k VNRX by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| VNRX | BUY | 2025-09-15 | $10K | — | Filing → |
| VNRX | BUY | 2025-08-06 | $50K | — | Filing → |
| VNRX | BUY | 2025-06-16 | $7K | — | Filing → |